graph Evidence gap map comparisons
poly ADP-ribose polymerase (PARP) inhibitor
veliparib plus paclitaxel plus carboplatin
mBC - TNBC - L1 - all population 7    
Comparator:  vs Standard of Care (SoC); 
Risk of bias:  low;   some concerns;   high;  NA;